Description

In this episode, Joseph J. Eron, Jr., MD, explores whether weight gain should or should not be a factor in determining initial therapy.

Listen as he gives his perspectives on:

• Weight gain following ART initiation by ARV class and ARV drug
• Results of the ADVANCE and GEMINI-1 and -2 studies, with exploration of weight, risk of CVD and diabetes
• BMI changes in PWH
• DHHS and IAS-USA guidelines for initial therapy

Presenter:

Joseph J. Eron, MD
Professor of Medicine and Epidemiology
University of North Carolina  
School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Follow along with the slides at:
https://bit.ly/3DyLgA3

See the entire program at:
https://bit.ly/2TXTYWx

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.